Related Experiment Videos
Chloroquine myopathy and neuropathy with elevated CSF protein
M Wasay1, G I Wolfe, J M Herrold
1Department of Neurology, University of Texas Southwestern Medical Center, Dallas 75235-8897, USA.
Neurology
|October 22, 1998
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Adjudicating Mild Cognitive Impairment Due to Alzheimer's Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical Trial.
The journal of prevention of Alzheimer's disease·2022
Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma.
Acta neuropathologica communications·2020
The World Federation of Neurology and the challenges in Environment Neurology.
Revue neurologique·2019
Neurological complications in patients with Plasmodium vivax malaria from Karachi, Pakistan.
The journal of the Royal College of Physicians of Edinburgh·2018
Using genetics to enable studies on the prevention of Alzheimer's disease.
Clinical pharmacology and therapeutics·2012
Neuroprotection of engineered Clostridium butyricum-pMTL007-GLP-1 in A53T α-synuclein (α-syn) mouse model via PI3K/AKT/GSK-3β.
Journal of Zhejiang University. Science. B·2026
Incidence and clinical characteristics of amyotrophic lateral sclerosis during the post-COVID-19 Period: a population-based study from Isfahan, Iran.
Neurodegenerative disease management·2026
Three Cases of Primary Central Airway Tumors of Neurological and Neuroendocrine Origin in Children.
Journal of pediatrics. Clinical practice·2026